NovaBay Pharmaceuticals (NBY) News Today $0.76 +0.01 (+1.34%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLCOctober 29, 2024 | finance.yahoo.comNovaBay Pharmaceuticals receives unsolicited offer from Refresh AcquisitionsOctober 29, 2024 | msn.comNovaBay Pharmaceuticals (AMEX:NBY) Stock, Short Interest ReportSeptember 26, 2024 | benzinga.comNovaBay Pharmaceuticals (AMEX:NBY) Stock Quotes, Forecast and News SummarySeptember 26, 2024 | benzinga.comWhat's Going On With NovaBay Pharmaceuticals Shares Friday?September 20, 2024 | msn.comNovaBay Pharmaceuticals, Inc. (B9P0.F)August 20, 2024 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | finance.yahoo.comNovaBay Pharmaceuticals Inc. Q2 Loss DropsAugust 13, 2024 | markets.businessinsider.comNovaBay Q2 2024 Earnings PreviewAugust 13, 2024 | msn.comNovaBay reports surge in Avenova sales during Prime DayAugust 1, 2024 | uk.investing.comNovaBay Pharmaceuticals Reports Record Amazon Prime Day SalesJuly 30, 2024 | finance.yahoo.comWhat's Going On With NovaBay Pharmaceuticals (NBY) Stock?July 29, 2024 | msn.comNovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment OptionJuly 29, 2024 | finance.yahoo.comDow Surges 550 Points; Headline PCE Price Index Falls To 2.5%July 27, 2024 | msn.comNovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public OfferingJuly 26, 2024 | finance.yahoo.comWhy NovaBay Pharmaceuticals (NBY) Stock Is Down 60%July 26, 2024 | benzinga.comNovabay Pharmaceuticals IncJuly 25, 2024 | money.usnews.comNovaBay Pharmaceuticals Stock Is Up 50%: What's Going On?May 20, 2024 | msn.comNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call TranscriptMay 13, 2024 | finance.yahoo.comNovaBay Pharmaceuticals is about to announce earnings — here's what Wall Street expectsMay 8, 2024 | markets.businessinsider.comNovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing ExpensesApril 17, 2024 | finance.yahoo.comBuy Rating Maintained for NovaBay Pharma Amid Strategic Refocus and Resilient Revenue PerformanceApril 17, 2024 | markets.businessinsider.comNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comQ4 2023 NovaBay Pharmaceuticals Inc Earnings CallMarch 27, 2024 | finance.yahoo.comNovaBay Pharmaceuticals Inc.March 15, 2024 | barrons.comNovaBay Pharmaceuticals To Sell DERMAdoctor Skincare Business - Quick FactsMarch 14, 2024 | markets.businessinsider.comNovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare ProfessionalsMarch 13, 2024 | markets.businessinsider.comNovaBay Pharmaceuticals, Inc. (NBY)February 26, 2024 | finance.yahoo.comNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based SalesJanuary 30, 2024 | finance.yahoo.comWhy ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving PremarketJanuary 29, 2024 | msn.comNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor NetworkJanuary 9, 2024 | finance.yahoo.comNovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic MembranesDecember 6, 2023 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call TranscriptNovember 12, 2023 | finance.yahoo.comRecap: NovaBay Pharmaceuticals Q3 EarningsNovember 9, 2023 | benzinga.comNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | finance.yahoo.comNovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023November 2, 2023 | finance.yahoo.comNovaBay Pharmaceuticals: CEO InterviewOctober 21, 2023 | thestreet.comNovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova ProgramsOctober 11, 2023 | finance.yahoo.comNovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth ConferenceOctober 2, 2023 | finance.yahoo.comNovaBay Pharma Shares Rise 42% After Deal With BioStem TechnologiesSeptember 11, 2023 | marketwatch.comNovaBay Pharma Agrees With BioStem To Commercialize Amniotic Tissue Allograft As Avenova AllograftSeptember 11, 2023 | markets.businessinsider.comWhy NovaBay Pharmaceuticals Stock Is Blasting HigherSeptember 11, 2023 | benzinga.comNovaBay stock soars 86% on optic allograft product dealSeptember 11, 2023 | msn.comNovaBay to Commercialize BioStem Technologies' Amniotic Tissue AllograftSeptember 11, 2023 | marketwatch.comNovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® AllograftSeptember 11, 2023 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finance.yahoo.comLadenburg Thalmann Maintains Novabay Pharmaceuticals (NBY) Buy RecommendationAugust 12, 2023 | msn.comQ2 2023 NovaBay Pharmaceuticals Inc Earnings CallAugust 11, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Reports Second Quarter 2023 Financial ResultsAugust 11, 2023 | finance.yahoo.com Get NovaBay Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW NBY Media Mentions By Week NBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBY News Sentiment▼0.580.46▲Average Medical News Sentiment NBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBY Articles This Week▼20▲NBY Articles Average Week Get NovaBay Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EDSA News INDP News BETRF News PHXM News RDHL News CDT News RNAZ News IMNN News ABVC News VIRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:NBY) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
